FDA
-
-
-
-
-
-
-
ClearPoint Neuro Completes Acquisition of IRRAS
-
-
-
-
-
-
-
ClearPoint Neuro gains regulatory approvals in Canada, Hong Kong, Taiwan
-
-
-
-
-
-
-
ClearPoint Neuro Reports Second Quarter 2025 Results
-
-
-
-
-
-
-
ClearPoint Neuro Inc. (CLPT) Announces FDA Submission to Expand the Labeling of ClearPoint Prism to Include 1.5 T MRI
-
-
-
-
-
-
-
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
-
-
-
-
-
-
-
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
-
-
-
-
-
-
-
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

